Director · Alto Neuroscience, Inc. · Alto Neuroscience, Inc. — Stock Option (right to buy)
Side
A
Value
$85K
Shares
7,189
Price
$11.82
Executed
Jan 2, 2026
Disclosed
Jan 6, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 2 executedJan 6, 2026 disclosed
ANRO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+4 / 25
$85K reported value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Alto Neuroscience, Inc. — Stock Option (right to buy)
Ticker
ANRO
Shares
7,189
Price per share
$11.82
Value
$84,974
Execution date (reported)
Jan 2, 2026
Owned after transaction
7,189 shares
Days from execution to publication
4
Calculation
Value = shares × reported price per share
Shares: 7,189
Price: $11.82
= $84,974
What this establishes
Cox Christopher Nixon filed this Form 4 reporting a grant or award of ANRO on Jan 2, 2026. It became public on Jan 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Cox Christopher Nixoncik:0002008212
Issuer
Alto Neuroscience, Inc.cik:0001999480
Revision history · 0
No field has changed since this record was first ingested.
